BenevolentAI Hub
Utilizes AI and machine learning for drug discovery and development, with a focus on various diseases.
Technology:
Artificial Intelligence, Big Data, Biotechnology, Machine Learning, Neuroscience
Industry:
AI, End-to-end Drug Development
Headquarters:
London, England, United Kingdom
Founded Date:
2013-11-13
Employees Number:
251-500
Funding Status:
IPO
Investors Number:
6
Total Funding:
292000000
Estimated Revenue:
$10M to $50M
Last Funding Date:
2019-09-17
Last Funding Type:
Private Equity
Register and Claim Ownership